Corrigendum: The Transition From Ambrisentan to Macitentan in Patients With Pulmonary Arterial Hypertension: A Real-Word Prospective Study

Detalles Bibliográficos
Autores principales: Chen, Yusi, Luo, Jun, Chen, Jingyuan, Kotlyar, Eugene, Li, Zilu, Chen, Wenjie, Li, Jiang
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Pharmacology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9035514/
https://www.ncbi.nlm.nih.gov/pubmed/35479317
http://dx.doi.org/10.3389/fphar.2022.891907

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9035514/
https://www.ncbi.nlm.nih.gov/pubmed/35479317
http://dx.doi.org/10.3389/fphar.2022.891907

Ejemplares similares